Multithread effectively and personalize outreach to convert deals faster
Elevate social presence and drive business growth from social media
Identify and prioritize high-intent leads, and improve sales effectiveness
Find and connect with ICP attendees, and improve event outcomes
Generation Bio is a clinical-stage biotechnology company committed to creating a new class of genetic medicines to provide durable, redosable treatments for people living with rare and prevalent diseases. The company is developing its proprietary non-viral drug delivery system, which includes closed-ended DNA (ceDNA) and cell-targeted lipid nanoparticles (ctLNP), designed to overcome the limitations of existing gene therapies. By enabling treatments that can be titrated and redosed, Generation Bio aims to make genetic medicine a lifelong option for a broader patient population, initially focusing on diseases of the liver and immune system.
The Cambridge headquarters serves as the central hub for Generation Bio's research and development, laboratory operations, corporate functions, and strategic leadership.
Situated in Kendall Square, the facility is part of a dynamic biotech ecosystem, featuring modern laboratory and office spaces designed to support cutting-edge genetic medicine research.
The work culture at Generation Bio likely fosters innovation, scientific rigor, collaboration, and a strong patient-centric focus, driven by the goal of revolutionizing genetic medicine.
Its Cambridge location provides Generation Bio with access to a rich talent pool, world-class academic institutions (like MIT and Harvard), and a dense network of potential partners, investors, and service providers crucial for biotech advancement.
While Generation Bio's primary operations are based in the United States, its mission to develop genetic medicines for diseases with high unmet need has global relevance. The company's research, clinical development, and potential future commercialization strategies are aimed at addressing patients worldwide, necessitating engagement with international regulatory bodies, research collaborators, and healthcare systems.
301 Binney Street
Cambridge
MA
USA
No additional office locations available.
Highperformr Signals uncover buying intent and give you clear insights to target the right accounts at the right time — helping your sales, marketing, and GTM teams close more deals, faster.
As of April 2025, Generation Bio' leadership includes:
Generation Bio has been backed by several prominent investors over the years, including:
Generation Bio experienced key leadership transitions in the past year, including the appointment of a new Chief Financial Officer and the departures of the former CFO and Chief Strategy Officer.
Discover the tools Generation Bio uses. Highperformr reveals the technologies powering your target accounts — helping your sales, marketing, and GTM teams prioritize smarter and close faster.
Generation Bio likely uses common corporate email formats. Based on industry patterns and available data, a frequent format is the first initial followed by the last name.
[first_initial][last]@generationbio.com
Format
jdoe@generationbio.com
Example
85%
Success rate
Generation Bio Investor Relations • May 9, 2024
Generation Bio announced its financial results for Q1 2024, highlighting progress in its ceDNA-based therapies for hemophilia A, a new research program for PKU, and advancements in its immune-quiet LNP delivery system....more
Generation Bio Investor Relations • February 27, 2024
The company reported Q4 and full-year 2023 financials, updating on its preclinical pipeline for hemophilia A and other liver-targeted diseases, and development of its ceDNA and ctLNP platforms....more
Generation Bio Investor Relations • November 13, 2023
Generation Bio announced the appointment of Matthew Norkunas, M.D., M.B.A., as its new Chief Financial Officer, effective November 27, 2023, succeeding Daniel Spiegelman....more
See where a company’s workforce is located, by country or region.
View past and recent funding rounds with amounts and investors.
Understand company revenue estimates and financial scale.
Track active roles and hiring trends to spot growth signals.
Discover what a company offers—products, platforms, and solutions.
Get the company’s official SIC and NAICS classifications.
Analyze visitor volume, engagement, and top traffic sources.
Explore LinkedIn, Twitter, and other active social profiles.
Identify top competitors based on similar business traits.
Explore companies in depth — from the tech they use to recent funding, hiring trends, and buyer signals — all in one powerful view.
Highperformr AI helps you surface the right accounts and enrich your CRM with verified company and contact insights, so your teams can prioritize and engage faster.
Thousands of companies, including Generation Bio, are just a search away.